Manufacture Contract Manufacturing Services, COVID-19, Profession, Standards & Regulation, Supply Chain, Vaccines

Adversity, Adaption, Delivery, Expansion

How one CDMO navigated the pandemic and came out on top

08/02/2022 | 8 min read | Discussion

sponsored by PCI

The pandemic changed pharma for good, transforming the ways that businesses “think” and function. Amid the turmoil, companies have pulled through – with many running at full speed for every single second of COVID-19’s “unforgiving minute.” PCI Pharma Services is one such company. We asked some of PCI’s leaders to meet and to discuss the moves they made to ensure the company’s growth in key areas, including sterile fill-finish and lyophilization capacity to support the increasing demand for end-to- end integrated solutions from development through to commercialization.

Tom McGrath: Vice President, Global Quality for Manufacturing and Development

Aimee Hodge: Vice President, Technical Services and Validation

Shawn Cain: Senior Vice President, Development and Manufacturing

Jeff Clement: Executive Director, Business Development, North America

Download pdf

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.